Ezt az oldalt automatikusan lefordították, és a fordítás pontossága nem garantált. Kérjük, olvassa el a angol verzió forrásszöveghez.

Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced Paresis (VAST-LDH)

2026. augusztus 12. frissítette: Teppo Jarvinen, Helsinki University Central Hospital

Validation of a Methodology Using Isometric Dynamometer for Ankle Strength Assessment to Quantify LDH-induced Paresis

Lumbar disc herniation (LDH) is a common condition that may cause lower limb motor weakness (paresis), particularly affecting ankle dorsiflexion and plantarflexion. Although motor deficits are clinically important and may influence treatment decisions, objective and standardized methods for quantifying the severity of paresis are lacking. Current clinical assessment mainly relies on manual muscle testing, which is subjective and has limited sensitivity, while isokinetic dynamometry, the reference standard for muscle strength assessment, is expensive and impractical for routine clinical use.

This prospective validation study aims to evaluate a clinically feasible isometric ankle strength measurement method based on a handheld dynamometer fixed with an external strap to eliminate examiner-dependent resistance. The study will be conducted in two sequential phases. First, validity and reliability of the method will be established in healthy adult volunteers by comparing measurements with those obtained using an isokinetic dynamometer. Second, the method will be applied in patients with LDH-induced lower limb paresis to determine its performance across a broader range of muscle strength values and its clinical applicability.

Outcome measures include maximal isometric ankle dorsiflexion and plantarflexion force, time to peak force, manual muscle testing (Medical Research Council scale), patient-reported weakness using a Numeric Rating Scale, Lower Extremity Functional Scale (LEFS) scores, and functional ankle strength tests. Validity will be assessed using correlation analyses and Bland-Altman agreement analysis, while intra- and inter-rater reliability will be evaluated using intraclass correlation coefficients, coefficient of variation, standard error of measurement, and minimum detectable change.

The study seeks to establish a reliable, valid, and clinically practical method for objective assessment of ankle muscle strength in patients with LDH-induced paresis. Such a method could improve clinical evaluation, enable objective monitoring of recovery, facilitate future clinical research, and support treatment decision-making.

A tanulmány áttekintése

Állapot

Jelentkezés meghívóval

Részletes leírás

Lumbar disc herniation (LDH) is one of the most common causes of lumbar radiculopathy and may result in lower limb motor weakness due to nerve root compression. While radicular pain often improves with conservative treatment, motor deficits may persist, recover slowly, or require surgical intervention. Despite the clinical importance of paresis, objective quantification of muscle weakness remains challenging because no standardized, practical, and validated measurement method is routinely available for clinical use.

Current clinical assessment primarily relies on manual muscle testing (MMT), which uses an ordinal grading system and is inherently subjective. MMT is limited by examiner experience, strength, and the inability to detect small but clinically meaningful changes in muscle function. Isokinetic dynamometry is widely regarded as the reference standard for objective muscle strength assessment because of its high accuracy and reproducibility. However, the equipment is expensive, non-portable, requires specialized training, and is therefore unsuitable for routine outpatient assessment or repeated follow-up measurements.

This study aims to validate a portable isometric ankle strength measurement method using a handheld dynamometer secured with an external fixation strap, minimizing examiner-related variability. The ultimate goal is to develop a clinically feasible method capable of objectively quantifying ankle dorsiflexion and plantarflexion strength in patients with LDH-induced paresis.

The study is designed as a prospective observational validation study conducted at Helsinki University Hospital. It consists of two consecutive phases.

During the first phase, healthy adult volunteers will undergo repeated ankle strength measurements using both the investigational handheld dynamometer method and an isokinetic dynamometer. This phase will establish criterion validity by comparing the handheld measurements with the reference standard. In addition, intra-rater and inter-rater reliability of the handheld method will be assessed through repeated measurements performed by different examiners.

If adequate validity and reliability are demonstrated, the second phase will recruit patients diagnosed with lumbar disc herniation presenting with clinically verified lower limb paresis. The objective of this phase is to evaluate whether the measurement method performs across the full spectrum of muscle weakness encountered in clinical practice and to determine its clinical relevance.

Primary measurements include maximal isometric ankle dorsiflexion and plantarflexion force and time to peak force. Secondary assessments include manual muscle testing according to the Medical Research Council grading system, patient-reported weakness using an 11-point Numeric Rating Scale, Lower Extremity Functional Scale (LEFS), and functional performance tests consisting of repeated toe raises and heel raises.

Criterion validity will be evaluated by comparing handheld dynamometer measurements with isokinetic dynamometer measurements using Pearson or Spearman correlation coefficients, linear regression analyses, and Bland-Altman plots to assess agreement and systematic bias. Construct validity will be examined by correlating objective strength measurements with patient-reported weakness, LEFS scores, and functional performance tests. Reliability will be assessed using intraclass correlation coefficients for both intra-rater and inter-rater agreement, together with coefficient of variation, standard error of measurement, and minimum detectable change.

Approximately 35 healthy volunteers and 35 patients with LDH-induced paresis will be recruited to allow for participant dropout while maintaining adequate statistical power based on previous validation studies.

The study involves no therapeutic intervention and poses minimal risk. Participants will undergo standardized muscle strength testing and complete patient-reported outcome measures. Any discomfort, such as muscle cramps or transient fatigue during testing, will be documented. Participants demonstrating clinically significant deterioration in muscle strength during the study will be referred for further clinical evaluation according to standard practice.

By establishing a valid, reliable, and practical method for objective ankle strength assessment, this study aims to improve the evaluation and longitudinal monitoring of patients with LDH-induced paresis. The validated methodology may facilitate future clinical trials, improve outcome assessment, enable earlier recognition of neurological recovery or deterioration, and support evidence-based treatment decisions in patients with lumbar disc herniation.

Tanulmány típusa

Beavatkozó

Beiratkozás (Becsült)

70

Fázis

  • Nem alkalmazható

Kapcsolatok és helyek

Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.

Tanulmányi helyek

    • Uusimaa
      • Helsinki, Uusimaa, Finnország, 00290
        • Helsinki University Central Hospital

Részvételi kritériumok

A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.

Jogosultsági kritériumok

Tanulmányozható életkorok

  • Felnőtt
  • Idősebb felnőtt

Egészséges önkénteseket fogad

Igen

Leírás

First phase

Inclusion Criteria:

  • Aged 18-65 years old
  • No pathology affecting ankle dorsiflexion or plantarflexion strength

Exclusion Criteria:

- Pathology affecting ankle dorsiflexion or plantarflexion strength

Second phase

Inclusion Criteria:

  • Aged 18-65 years old
  • LDH-induced muscle weakness of ankle dorsiflexion or plantarflexion

Exclusion Criteria:

- No muscle weakness induced by herniated lumbar disc

Tanulási terv

Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.

Hogyan készül a tanulmány?

Tervezési részletek

  • Elsődleges cél: Egyéb
  • Kiosztás: N/A
  • Beavatkozó modell: Egyetlen csoportos hozzárendelés
  • Maszkolás: Nincs (Open Label)

Fegyverek és beavatkozások

Résztvevő csoport / kar
Beavatkozás / kezelés
Egyéb: Study participant
Person participating in validity and reliability assessment
Ankle dorsiflexion and plantarflexion isometric maximal voluntary contraction strength test

Mit mér a tanulmány?

Elsődleges eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Criterion validity of the isometric handheld dynamometer
Időkeret: At baseline (first measurement session; Day 0)
Agreement between the investigational isometric handheld dynamometer (HHD) measurement method and the reference standard isokinetic dynamometer (IKD) for maximal ankle dorsiflexion and plantarflexion strength.
At baseline (first measurement session; Day 0)
Construct validity of the handheld dynamometer
Időkeret: At baseline (first measurement session; Day 0)
Correlation of HHD measurements with patient-reported weakness (Numerical Rating Scale), Lower Extremity Functionality Scale questionnaire, manual muscle testing (Medical Research Council grade) and functional ankle performance tests.
At baseline (first measurement session; Day 0)
Intra-rater reliability of the handheld dynamometer
Időkeret: At baseline (Day 0) and at the second measurement session, within 7 days after baseline
Test-retest reliability of ankle dorsiflexion and plantarflexion strength measurements obtained by the same examiner.
At baseline (Day 0) and at the second measurement session, within 7 days after baseline
Inter-rater reliability of the handheld dynamometer
Időkeret: At the second measurement session, within 7 days after baseline
Agreement between measurements performed by different examiners
At the second measurement session, within 7 days after baseline

Egyéb eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Maximal isometric ankle dorsiflexion strength
Időkeret: At baseline (first measurement session; Day 0)
Maximum voluntary isometric dorsiflexion force measured using the handheld dynamometer
At baseline (first measurement session; Day 0)
Maximal isometric ankle plantarflexion strength
Időkeret: At baseline (first measurement session; Day 0)
Maximum voluntary isometric plantarflexion force measured using the handheld dynamometer.
At baseline (first measurement session; Day 0)
Time to peak force
Időkeret: At baseline (first measurement session; Day 0)
Time required to reach maximal voluntary isometric force during dorsiflexion and plantarflexion.
At baseline (first measurement session; Day 0)
Manual Muscle Testing (Medical Research Council scale)
Időkeret: At baseline (first measurement session; Day 0)
Ankle muscle strength (plantarflexion and dorsiflexion) assessed using the Medical Research Council (MRC) 0-5 manual muscle testing scale (0 = no muscle contraction, 5 = normal strength)
At baseline (first measurement session; Day 0)
Participant-reported lower limb weakness (Numeric Rating Scale)
Időkeret: At baseline (first measurement session; Day 0)
Self-reported severity of lower limb weakness measured using an 11-point Numeric Rating Scale (0 = no weakness, 10 = worst imaginable weakness).
At baseline (first measurement session; Day 0)
Participant reported function (Lower Extremity Functional Scale, LEFS)
Időkeret: At baseline (first measurement session; Day 0)
Lower extremity function assessed using the Lower Extremity Functional Scale (score range 0-80, higher scores indicate better function).
At baseline (first measurement session; Day 0)
Functional ankle performance testing (heel raises, toe raises)
Időkeret: At baseline (first measurement session; Day 0)
Functional ankle performance assessed by the maximum number of heel raises (plantarflexion) and toe raises (dorsiflexion).
At baseline (first measurement session; Day 0)
Participant-reported discomfort during measurements
Időkeret: From baseline (Day 0) through completion of the second measurement session, up to 7 days after baseline
Occurrence of adverse symptoms during testing, including but not limited to muscle cramps, discomfort, or pain.
From baseline (Day 0) through completion of the second measurement session, up to 7 days after baseline

Együttműködők és nyomozók

Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.

Tanulmányi rekorddátumok

Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.

Tanulmány főbb dátumok

Tanulmány kezdete (Becsült)

2026. augusztus 10.

Elsődleges befejezés (Becsült)

2026. október 1.

A tanulmány befejezése (Becsült)

2026. december 1.

Tanulmányi regisztráció dátumai

Először benyújtva

2026. július 8.

Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak

2026. augusztus 12.

Első közzététel (Tényleges)

2026. augusztus 13.

Tanulmányi rekordok frissítései

Utolsó frissítés közzétéve (Tényleges)

2026. augusztus 13.

Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak

2026. augusztus 12.

Utolsó ellenőrzés

2026. augusztus 1.

Több információ

A tanulmányhoz kapcsolódó kifejezések

Terv az egyéni résztvevői adatokhoz (IPD)

Tervezi megosztani az egyéni résztvevői adatokat (IPD)?

IGEN

IPD terv leírása

De-identified individual participant data underlying the results reported in the publication, including ankle strength measurements, functional outcome measures, and participant characteristics.

IPD megosztási időkeret

10 years after publication

IPD-megosztási hozzáférési feltételek

Researchers who provide a methodologically sound research proposal.

Data will be available upon reasonable request to the principal investigator, subject to institutional approval, applicable legislation, and a data sharing agreement.

Az IPD megosztását támogató információ típusa

  • STUDY_PROTOCOL
  • NEDV

Gyógyszer- és eszközinformációk, tanulmányi dokumentumok

Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz

Nem

Egy amerikai FDA által szabályozott eszközterméket tanulmányoz

Nem

Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .

Iratkozz fel